# The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer

> **NCT06975384** · — · RECRUITING · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 1270 (estimated)

## Conditions studied

- Lung Cancer
- Sleep Disturbance
- Immune Checkpoint Inhibitors
- Cancer, Treatment-Related

## Interventions

- **OTHER:** Exposure: sleep disturbance status

## Key facts

- **NCT ID:** NCT06975384
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 1270 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06975384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06975384, "The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06975384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*